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Available online 14 December 2013Abstract Embryonic stem cells (ESCs) need to maintain their genomic integrity in response to DNA damage to safeguard the
integrity of the organism. DNA double strand breaks (DSBs) are one of the most lethal forms of DNA damage and, if not repaired
correctly, they can lead to cell death, genomic instability and cancer. How human ESCs (hESCs) maintain genomic integrity in
response to agents that cause DSBs is relatively unclear. In the present study we aim to determine the hESC response to the DSB
inducing agent camptothecin (CPT). We find that hESCs are hypersensitive to CPT, as evidenced by high levels of apoptosis. CPT
treatment leads to DNA-damage sensor kinase (ATM and DNA-PKcs) phosphorylation on serine 1981 and serine 2056,
respectively. Activation of ATM and DNA-PKcs was followed by histone H2AX phosphorylation on Ser 139, a sensitive reporter of
DNA damage. Nuclear accumulation and ATM-dependent phosphorylation of p53 on serine 15 were also observed. Remarkably,
hESC viability was further decreased when ATM or DNA-PKcs kinase activity was impaired by the use of specific inhibitors. The
hypersensitivity to CPT treatment was markedly reduced by blocking p53 translocation to mitochondria with pifithrin-μ.
Importantly, programmed cell death was achieved in the absence of the cyclin dependent kinase inhibitor, p21Waf1, a bona fide
p53 target gene. Conversely, differentiated hESCs were no longer highly sensitive to CPT. This attenuated apoptotic response
was accompanied by changes in cell cycle profile and by the presence of p21Waf1. The results presented here suggest that p53
has a key involvement in preventing the propagation of damaged hESCs when genome is threatened. As a whole, our findings
support the concept that the phenomenon of apoptosis is a prominent player in normal embryonic development.
© 2013 Elsevier B.V. All rights reserved.⁎ Corresponding author.
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Human embryonic stem cells (hESCs) are a unique cell
population derived from the inner cell mass of blastocyst
stage embryos (Thomson et al., 1998). These unique cells
possess an unlimited potential to proliferate (self-renewal)
and the ability to generate and differentiate into most cell
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should have a highly sensitive and finely tuned response to
DNA damage to protect its genome integrity and avoid
proliferative defects that may cause lethality. Furthermore,
unrepaired or misrepaired DNA lesions can lead to mutations
and large scale genome alterations that may compromise
cell lineages and affect the well-being of subsequent
generations of hESCs. Conversely, somatic cells have
genomic requirements that are very different from those
of ESCs. Somatic cells have restricted patterns of gene
expression characteristic of their specific differentiated
lineages. Hence, the consequences of mutation in a somatic
cell are limited to that particular cell lineage and may
result in somatic diseases, e.g., cancer, but will not be
passed on to the progeny.
Camptothecin (CPT) is a highly selective topoisomerase I
inhibitor (Liu et al., 2000; Pommier and Cherfils, 2005). This
reagent converts topoisomerase I, an essential enzyme in higher
eukaryotes, to a cellular poison when replication forks collide
with CPT-trapped topoisomerase I cleavage complexes
(Pommier, 2006). The resulting lesions are replication-mediated
DNA double-strand breaks (DSBs) (Strumberg et al., 2000).
A common step following replication-mediated DSBs is
the activation of sensor kinases belonging to the family
of phosphatidylinositol 3-kinase-related kinases (PIKKs)
(Abraham, 2004). In somatic cells, three PIKKs are activated
by topoisomerase I-induced replication mediated DSBs: ataxia
teleangectasiamutated (ATM), ataxia teleangectasia mutated
and Rad3 related (ATR), and DNA-dependent protein kinase
catalytic subunit (DNA-PKcs) (Rao et al., 2005;Ward and Chen,
2001). ATM, ATR and DNA-PKcs activate the DSB signaling
pathways by phosphorylating a range of nuclear proteins,
which includes histone H2A variant H2AX and p53 (Sordet et al.,
2009; Zhao et al., 2008). Phosphorylation of histone H2AX on
serine 139 generates γH2AX, a sensitive and early marker for
DSBs (Sedelnikova et al., 2003). The formation and resolution of
γH2AX is linked to the presence of DSBs and can act as a
surrogate for DNA damage and DSB repair. On the other hand,
phosphorylation of p53 on serine 15 promotes its activation and
fine-tunes its response to DNA damage (Adams et al., 2010).
p53 is a representative tumor suppressor which plays an
important role in the regulation of the DNA damage response.
In somatic cells, under normal physiological conditions, p53
expression levels and half-life are low. In response to a variety
of cellular stressors, p53 is quickly induced and accumulates in
cell nucleus. Upon severe DNA damage, p53 induces apoptosis
to eliminate damaged cells. Apoptosis induction by p53 can
occur via both transcription-dependent and transcription-
independent pathways. The classical transcription-dependent
pathway involves stabilization of p53 protein via post-
translational modifications, nuclear translocation, and subse-
quent transactivation of pro-apoptotic genes, such as PUMA,
Noxa and Bax (Oren, 2003), as well as repression of anti-
apoptotic genes such as Bcl-2 and IAPs (Lu, 2005). p53 can also
trigger apoptosis via a transcription-independent pathway
that involves rapid translocation of a proportion of total
cellular p53 directly to the mitochondria and its interaction
with the Bcl-2 family members (Chipuk et al., 2004).
Conversely, when cells receive repairable DNA damage, p53
promotes cell cycle arrest by transactivating the cyclin
dependent kinase inhibitor (CKI) p21Wa’f1 to allow DNA repair
(Oren, 2003).Embryonic stem cells progress rapidly through the cell
cycle with an unusually short G1 phase (Becker et al., 2006).
This unusual cell cycle structure is accompanied by high
levels of cyclin-dependent kinase (CDK) activity which is a
consequence of the absence or very weak expression of CKIs
(Kapinas et al., 2013). Importantly, molecular pathways
governing the G1/S transition also play key roles in the DNA
damage response and maintenance of genome integrity. In
this sense, as hESCs differentiate, the cell cycle structure is
remodeled with the G1 phase being markedly lengthened
(Filipczyk et al., 2007). These changes in cell cycle dynamics
are paralleled by a robust up-regulation of CKIs' mRNA and
protein levels.
In this study, we investigated the response of hESCs to the
induction of DNA replication stress triggered by CPT. We find
that hESCs exhibit high apoptosis rates in response to CPT.
Using diverse biochemical and cellular approaches, we
determined that DNA-damaged hESCs have functional ATM
and DNA-PKcs pathways. Additionally, we present evidence
that these PI3KK family members jointly contribute to H2AX
phosphorylation, and that CPT treatment leads to p53
stabilization, serine 15 phosphorylation and nuclear accu-
mulation. Importantly, the impairment of p53 translocation
to mitochondria with pifithrin-μ ameliorates cell death. The
massive apoptosis of hESCs occurs in the absence of p21Waf1
protein, despite a marked up-regulation of p21Waf1 mRNA
levels. Finally, we determined that hESCs at day 14 of the
differentiation onset are much less sensitive to CPT than
their undifferentiated counterparts. This increase in cell
viability is accompanied by p53 stabilization and p21Waf1
mRNA and protein induction, concomitantly with a marked
decrease in the percentage of cells residing in the S phase.
The results presented here prompted us to hypothesize that
in hESCs the proapoptotic activity of p53 might prevail to
safeguard genome integrity in response to DNA damage.Materials and methods
Cell culture
The human embryonic stem cell (hESC) line, WA09 (H9), was
purchased from WiCell Research Institute (WI) and the hESC
line, HUES-5 (H5) was acquired from Harvard University and
the Howard Hughes Medical Institute (MA) at low passages
(p15 to p20). The hESC lines were maintained on a mitotically
inactive (via irradiation) mouse embryonic fibroblast (iMEF)
feeder layer in medium comprised of Dulbecco's Modified
Eagle's Medium/Ham's F12 (DMEM/F12) supplemented with
20% knockout serum replacement (KSR), 2 mM non-essential
amino acids, 2 mM L-glutamine, 100 U/ml penicillin, 50 μg/ml
streptomycin, 0.1 mM β-mercaptoethanol and 4 ng/ml of
bFGF. All these reagents were obtained from Invitrogen
(Carlsbad, CA, USA). For the experiments, hESCs were
transferred with 1 mg/ml collagenase IV (Invitrogen, CA,
USA) into feeder-free diluted (1/40) Matrigel™ (BD Biosci-
ence, San Jose, CA, USA) coated dishes containing iMEF
conditioned medium. For conditioning medium, 3 × 106
inactivated MEFs were incubated for 24 h with 25 ml of
DMEM/F12 medium supplemented with 5% KSR and 2 ng/ml
of bFGF (in addition to the other aforementioned supple-
ments) and stored at −20 °C. After thawing, fresh aliquots
402 C.P. García et al.of KSR and bFGF were added to the medium to render a
final concentration of 20% and 4 ng/ml respectively.
To induce differentiation, hESC colonies were treated with
1 mg/ml collagenase type IV (Invitrogen, Carlsbad, CA, USA) for
5 min, followed by mechanical scraping. The dissociated small
clumps were then transferred to non-adherent Petri dishes and
cultured in DMEM supplemented with 20% (vol/vol) fetal bovine
serum (Gibco, CA, USA), 2 mM L-glutamine, 100 U/ml penicillin
and 50 μg/ml streptomycin, used as a differentiation medium.
The cells were incubated in suspension at 37 °C with 5% CO2 for
7 days. During the incubation, the suspended hESC clumps
aggregated to form three-dimensional non-adherent embryoid
bodies (EBs), which were then plated onto 0.1% gelatin coated
24-well microplates and cultured for an additional 7 days.
Human foreskin fibroblasts were prepared as primary
cultures from freshly obtained human foreskins as soon as
possible after surgery. Written informed consent was obtained
from patients according to guidelines established by the Ethics
Committee of our institution. Briefly, after fat and loose fascia
removal, surgically discarded tissue was trimmed into strips
(approximately 0.5 cm × 1.5 cm) using a sterile scalpel. The
cut tissuewas subjected to an overnight digestionwith dispase
(Invitrogen, CA, USA) and then followed by careful removal of
the epidermis. The remaining dermis was placed in high
glucose DMEM, 10% FBS (vol/vol), plated onto tissue culture
plates and incubated in a 37 °C, 5% CO2, 90% humidity
incubator. Within 7–10 days outgrowths of fibroblasts ap-
peared. The isolated fibroblasts were then expanded, frozen
and stored as described elsewhere.Inhibitors
2-Morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU55933)
(Calbiochem, San Diego, CA, USA), (2-(morpholin-4-yl)-benzo
[h]chomen-4-one) (NU7026) and pifithrin-μ (Sigma, St. Louis,
MO, USA) were dissolved in DMSO and stored at −20 °C.
Inhibitors were added to cell cultures such that the final DMSO
concentrations were kept constant at 0.25% (v/v). Stock
solutions of caffeine were prepared as 100 mM in PBS (Sigma,
St. Louis, MO, USA).Figure 1 Cell death induced by CPT in hESC line WA09 (H9). (A) H
with increasing concentrations of CPT (0.1–10 μM) over a 3 h period
or 12 h after drug removal. Results are presented as the percenta
mean ± SEM of three independent experiments performed in quint
treated samples to untreated controls (*P b 0.05). (B) Cell cycle
cytometry analysis based on DNA content. (C) Representative images
treated or not with 1 μM CPT over a 3 h period (left panel); histog
Trypan blue exclusion method 6 h post CPT removal (middle panel)
were quantified by immunoassay (right panel). Results are presented
represents the mean ± SEM of three independent experiments perf
used to compare CPT treated samples to untreated controls (*P b 0
untreated H9 cells. The figure shows hESCs stained with primary an
and PARP-1. The nuclei were counterstained with DAPI. Photos w
treatment (3 h), or 6 h post CPT removal (3 + 6 h). The scale bars re
are shown. (E) Time course of caspase-9 and PARP cleavage in hES
anti-caspase-9 and anti-PARP specific antibodies, immediately after
Actin was used as loading control.Immunostaining and fluorescence microscopy
The hESCs were analyzed for in situ immunofluorescence.
Briefly, the cells were rinsed with ice-cold PBS and fixed in
PBSA (PBS with 0.1% bovine serum albumin) with 4% formalde-
hyde for 45 min. After two washes, cells were permeabilized
with 0.1% Triton X-100 in PBSA with 10% normal goat serum for
30 min, washed twice and stained with the corresponding
primary antibodies. Fluorescent secondary antibodies were
used to localize the antigen/primary antibody complexes. The
cells were counterstained with DAPI and examined under a
Nikon Eclipse TE2000-S inverted microscope equipped with a
20× E-Plan objective and a super high-pressure mercury lamp.
The images were acquired with a Nikon DXN1200F digital
camera, which was controlled by the EclipseNet software
(version 1.20.0 build 61). The following primary antibodies
were used: anti-Oct-3/4 (clone C-10) (sc-5279), anti-PARP
(sc-8007) (Santa Cruz Biotechnology, Santa Cruz, CA, USA),
anti-active Caspase-3 (ab13847), this antibody preferentially
recognizes the 17 kDa fragment of the active Caspase-3
(Romorini et al., 2012), anti-pATM (ab81292), anti-γH2AX
(ab2893), anti-p53 (ab1101), anti-p73[EP436Y] (ab40658),
anti-pSer2056DNA-PKcs (ab181192) (Abcam Inc., Cambridge,
MA, USA) and anti-pSer15p53 (cat. 9284) (Cell Signaling
Technology, Beverly, MA, USA).
Western blotting
Cells were lysed in ice-cold RIPA buffer supplemented with a
protease inhibitor mixture, and protein concentration was
determined using the Bicinchoninic Acid Protein Assay (Pierce™,
Rockford, IL, USA). Equal amounts of protein were run on 12%
polyacrylamide gel electrophoresis, and transferred to PVDF-FL
membrane (Millipore, Billerica, MA, USA). The membrane was
blocked for 1 h in Odyssey blocking buffer (LI-COR Biosciences,
Lincoln, NE, USA) containing 0.1% Tween 20 and then incubated
overnight at 4 °C in a solution containing Odyssey blocking
buffer, 0.05% Tween 20 and the corresponding primary an-
tibodies. Themembranewas washed 4 times for 5 min with TBS
containing 0.1% Tween 20 (TTBS), then incubated for 1 h in a9 cells and human foreskin fibroblasts (HFs) were treated or not
. Cell viability was measured by the XTT/PMS vital dye assay at 6
ge of the viability of untreated cells. Each bar represents the
uplicates. A paired Student's t test was used to compare CPT
distribution of asynchronously growing H9 determined by flow
of H9 colonies grown on Matrigel™ coated surfaces for 3 days and
ram shows quantitative percentage of viable cells assessed by
; after CPT treatment cells were harvested, and DNA oligomers
as the percentage of DNA oligomers of untreated cells. Each bar
ormed in triplicates (right panel). A paired Student's t test was
.05). (D) Immunofluorescence staining of CPT-treated (1 μM) or
tibodies against cleaved-caspase-3 recognizing 17 kDa fragment
ere captured at different time points: immediately after CPT
present 100 μm. Representative images and 200% magnifications
Cs upon CPT treatment was analyzed by Western blotting with
(3 h), 6 or 12 h post drug removal (3 + 6, 3 + 12, respectively).
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and IR-Dye secondary antibodies (1:20.000, LI-COR Biosciences,
Lincoln, NE, USA) and subsequently washed 4 times for 5 min in
TTBS, and then 1 time for 5 min in TBS. The membrane was
immediately scanned for protein bands using the 680 nm and
780 nm channels at a scanning intensity of 4. Immunocomplexes
were visualized using the Odyssey Infrared Imaging System(LI-COR). The following primary antibodies were used: anti-
Actin (sc-1616), anti-caspase-9 (cat. 9502) (Cell Signaling
Technology, Beverly, MA, USA), anti-PARP, that recognizes the
C terminus of PARP-1 (sc-8007) (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), anti-p27Kip1 (clone C-1) (sc-528) (Santa
Cruz, CA, USA), anti-p53 (ab1101), anti-p73[EP436Y] (ab40658)
(Abcam Inc., Cambridge, MA, USA), anti-pSer15p53 (cat. 9284)
404 C.P. García et al.(Cell Signaling Technology, Beverly, MA, USA) and anti-p21Waf1
(cat. 556430) (BD Pharmingen™, Becton-Dickinson, San Jose,
California, USA). Antigen/primary antibody complexes were
detected with near infrared-fluorescence-labeled, IR-Dye
800CW or IR-Dye 680RD, secondary antibodies (LI-COR
Biosciences, Lincoln, NE, USA).
Reverse transcription polymerase chain reaction
Total RNA was extracted using TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) according to manufacturer's instructions.
cDNA was synthesized using MMLV reverse transcriptase
(Promega, Madison, WI, USA) from 500 ng of total RNA. The
cDNA samples were diluted fivefold. Quantitative PCR studies
were carried out using SYBR® Green-ER™ qPCR SuperMix UDG
(Invitrogen, Carlsbad, CA, USA) and the primer sequences used
are detailed in Supplementary Table 1. All samples were
analyzed using an ABI PRISM 7500 Sequence Detector System
(Applied Biosystems, Foster City, CA, USA) and were normal-
ized to GAPDH gene expression.
Flow cytometry analysis of cell cycle distribution
Single-cell suspensions of H9 cells were obtained by
treatment with acutasse 1× (Invitrogen, CA, USA) (37 °C
for 5–10 min). Floating cells were collected, pelleted and
washed twice with PBS. For DNA content analysis, cells
were fixed in 70% ethanol, rehydrated in PBS, and treated
for 30 min with RNase A (1 mg/ml) and for 5 min with
propidium iodide (PI) (1 mg/ml). Fluorescence intensity
was determined by flow cytometry on a FACScan equipped
with a 488-nm argon laser (Becton, Dickinson and Company,
Franklin Lakes, NJ, USA). Data acquisition was performed with
the CellQuest (Becton, Dickinson and Company, NJ, USA)
software, and the percentages of G1, S, and G27M-phase cells
were calculated with the MODFIT-LT software program (Verity
Software House, Topsham, ME, USA). For synchronization,
hESCs were blocked with 100 ng/ml nocodazol (Sigma,
St. Louis, MO, USA) over a 16 h period. Then, the cells were
harvested and analyzed by flow cytometry for cell cycle
distribution as described above.
Cell viability assay
hESCs were plated onto Matrigel™ coated 96-well tissue
culture plates at densities between 1 × 104 and 3 × 104 cells
per well and grown until confluence. A comparable number
of EBs were adhered on gelatin coated 48-well plates at day
7, and grown until day 14 of differentiation. At the indicated
time points post CPT removal, 50 μg/well of activated
2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5 [(phenylamino)
carbonyl]-2H-tetrazolium hydroxide (XTT) (Sigma, St. Louis,
MO, USA) in PBS containing 0.3 μg/well of the intermediate
electron carrier, N-methyl dibenzopyrazine methyl sulfate
(PMS) (Sigma, St. Louis, MO, USA) was added (final volume
100 μl) and incubated for 2–3 h at 37 °C. Cellular metabolic
activity was determined by measuring the absorbance of the
samples with a multiplate spectrophotometer (Benchmark,
Bio-Rad, Hercules, CA, USA) at a wavelength of 450 nm and
subtracting the background absorbance at 690 nm.Trypan blue staining
For Trypan blue exclusion assay, cells were seeded in 6-well
plates at a density of 1 × 105 cells/ml. At the indicated time
points after treatment, both the adherent and detached
cells were collected and stained with 0.4% Trypan blue
solution (final concentration 0.08%) (Sigma, St. Louis, MO,
USA) for 5 min at room temperature. Cells stained blue
(dead) and unstained (live) were counted in a hemocytometer
chamber. Percentages of viable cells were calculated as total
number of live cells divided by total number of cells and
multiplied by 100.
Flow cytometric determination of apoptosis by
Annexin V/propidium iodide double staining
FITC-Annexin V Apoptosis Detection Kit I was used to measure
cell death by flow cytometry according to the manufacturer's
instructions (BD Bioscience, Heidelberg, Germany). Briefly,
following two washing steps with PBS, the cell pellets were
re-suspended in 1× Binding Buffer (0.01 M HEPES pH 7.4,
0.14 M NaCl and 2.5 mM CaCl2) at a concentration of
1 × 106 cells/ml. Each sample (100 μl of the solution,
1 × 105 cells) was transferred to a tube and was stained
by addition of 5 μl annexin V-FITC and 5 μl propidium iodide.
After incubation in the dark for 15 min at room temperature,
400 μl of 1× Binding Buffer was added to each tube and cell
suspensions were analyzed by flow cytometry within 1 h. Data
was acquired on a BD Accuri C6 flow cytometer using BD Accuri
C6 software.
Assessment of DNA fragmentation
CPT-induced apoptosis was quantified by direct determination
of nucleosomal DNA fragmentation with Cell Death Detection
ELISAPlus kit (Roche, Mannheim, Germany). This assay uses
specific monoclonal antibodies directed against histones from
fragmented DNA, allowing the determination of mono and
oligonucleosomes in the cytoplasmic fraction of cell lysates.
Briefly, 2 × 105 hESCs were plated on 24-well plates in 500 μl
culture medium. Three hours after CPT addition (1 μM), cells
were lysed according to the manufacturer's manual, followed
by centrifugation (200 ×g, 5 min). Alternatively, pifithrin-μ
(10 μM) was added to the medium 1 h before and during
treatment with CPT. The mono and oligonucleosomes in the
supernatants were determined using an anti-histone-biotin
antibody. The resulting color development, which was propor-
tional to the amount of nucleosomes captured in the antibody
sandwich, was measured at 405 nm wavelength using a
Benchmark microtiter plate reader (Bio-Rad Hercules, CA,
USA). Results were expressed as DNA oligomer percentage,
calculated from the ratio of absorbance of treated samples to
that of the untreated ones.
Statistical analysis
All results are expressed as the mean ± SEM. The Student's
paired t-test was used to determine significant differences
between means, and P values below 0.05 were considered to
be statistically significant.
Figure 2 DNA-damage signaling in CPT exposed hESCs. (A): Immunofluorescence staining of CPT-treated (1 μM over a 3 h period) or
untreated H9 and H5 cells. The figure shows representative images of hESCs stained with primary antibodies against ATM
phospho-serine 1981 (pATM), Oct-4, a key factor that governs pluripotency and self-renewal in hESCs, histone H2AX phospho-serine
139 (γH2AX) and DNA-PKcs phospho-serine 2056 (pDNA-PKcs). (B) Fluorescent immunoreactivity of γH2AX in H9 pretreated with
100 μM KU55933, 10 mM caffeine or 50 μM NU7026 for 1 h and exposed to 1 μM CPT for 3 h. The scale bars represent 100 μm. (C) H9
cells were pretreated with KU55933 (100 μM) or NU7026 (50 μM) 1 h and during CPT exposure (1 μM over a 3 h period). Cell viability
was measured by the XTT/PMS vital dye assay at 6 h after drug removal. Results are presented as the percentage of the viability of
untreated cells. Histogram shows quantitative percentage of viable cells assessed by Trypan blue exclusion method 6 h post CPT
removal. Each bar represents the mean ± SEM of three independent experiments performed in quintuplicates. A paired Student's t
test was used to compare samples in the presence or absence of each inhibitor (*P b 0.05).
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CPT promotes apoptosis in hESCs
First, we evaluated the effect of CPT on WA09 (H9) hESC
viability. To do so, we determined the percentage of surviving
cells at different time points post CPT removal using a XTT/PMS
vital dye assay. The percentage of surviving cells decreased to
approximately 40% as soon as 6 h and further after genotoxic
removal. Viability was significantly reduced to the same extent
when hESCs were exposed to CPT during 3 h at concentrations
ranging from 0.1 to 10 μM (Fig. 1A). Similar results were
obtained when live and dead cells were counted using Trypan
blue dye-exclusion assay. As shown in Fig. 1C (middle panel)
the percentage of viable cells markedly decrease 6 h after drug
removal. Conversely, the number of viable human primary
foreskin fibroblasts (HF) slightly decreased to 80% after a
withdrawal period of 12 h, when cultured for 3 h in the
presence of 10 μM CPT (Fig. 1A). Interestingly, we determined
that 10–15% of H9 cells grown on Matrigel coated surfaces
were undergoing spontaneous cell death (Fig. 1C, middle
panel).
With some exceptions, hESCs divide rapidly with gener-
ation times of 8–16 h. H9 cells were synchronized at the G2
phase with nocodazole (100 ng/ml, 16 h) (Supplementary
Fig. 1A) and then were analyzed for cell cycle position every
3 h after drug removal by flow cytometry (data not shown).
In accordance with previous data (Becker et al., 2006), we
determined that the total time required for cell division of
these pluripotent cells is 16 ± 0.5 h, with an estimated time
for G1 of approximately 2.5–3 h, an S phase of 8 h and a
combined period of G2/M of 5 h. Thus, at any given time,
almost 60–65% of hESCs reside in S phase (Fig. 1B). This may
explain, at least in part, the high decrease in cell viability
observed upon CPT treatment especially if we consider that
the primary mechanism by which CPT kills cells is through S
phase specific cytotoxicity. Moreover, damaged H9 cells
exhibited a progressive ballooning, shrinking and detach-
ment from Matrigel™ coated surfaces (Fig. 1C, left panel).
These morphological changes are suggestive of apoptotic
processes.
Phosphatidylserine (PS) translocation from the inner to the
outer leaflet of the plasma membrane has been considered a
characteristic feature of apoptosis. So, to determine if CPT
induces apoptosis in H9 cells, we examined PS exposure and
plasma membrane integrity simultaneously by annexin V (aFigure 3 CPT triggers p53 stabilization and phosphorylation at S
phosphorylation at serine 15 in hESCs upon CPT treatment was analyze
(p53pSer15) specific antibodies, immediately after (3 h), 6 or 12 h p
as loading control. (B) Immunofluorescence staining of CPT-treated (1
hESCs stained with primary antibodies against p53, p53pSer15 and p73 (
Photos were captured immediately after CPT treatment (1.5 or 3 h). Th
p53pSer15 in H9 cells pretreated with 100 μM KU55933 or 10 mM ca
represent 50 μm. (D) After CPT treatment (1 μM over a 3 h period)
immunoassay. Results are presented as the percentage of DNA oligome
independent experiments performed in triplicates (left panel). Cell viab
removal in PFT-μ treated or untreated cells (10 μM, 1 h before and dur
viability of untreated cells (middle panel). Histogram shows quantitative
6 h post CPT removal in PFT-μ treated or untreated cells (right pa
experiments performed in quintuplicates. In all cases, a paired Student's
treated ones (*P b 0.05).phospholipid-binding protein with high affinity for PS) and
propidium iodide (PI) double staining. Importantly, PI can only
penetrate the plasma membrane when membrane integrity is
breached, as occurs in the later stages of apoptosis or in
necrosis. So, in this assay, apoptotic cells are positive for
annexin V but negative for PI. By flow cytometry analysis, we
detected an increased number of annexin V+/PI− cells after
CPT exposure, concomitant with a decrease in the number of
live cells (annexin V−/PI−). The number of annexin V+/PI+ cells
remained less than 10% during the timeframe of the experi-
ments (Supplementary Fig. 1D). Moreover, CPT-induced cell
death in H9 cells was accompanied by a significant increase in
the percentage of subG1 cells with a subdiploid DNA content
indicating DNA degradation (Supplementary Fig. 1C).
The uniform degradation of genomic DNA into oligomers of
approximately 180–200 bp, or multiples of that, characterizes
inter-nucleosomal cleavage of DNA and constitutes a bio-
chemical hallmark of apoptosis. Thus, to investigate whether
the loss of cell viability was due to CPT-induced apoptosis, we
determined cell death levels of treated and untreated H9
hESCs by quantifying DNA oligomers with an enzyme-linked
immunosorbent assay (ELISA), using monoclonal antibodies
directed against DNA and histones. As shown in Fig. 1C (right
panel) a marked increase in the percentage of DNA oligomers
was observed immediately after CPT removal (1 μM, 3 h) in H9
damaged cells.
Many apoptotic triggers culminate in the activation of
caspase cascades. Thus, to evaluate whether topoisomerase I
inhibition leads to caspase activation in H9 cells, we performed
Western blot analysis and find that 3 h after CPT treatment,
initiator pro-caspase-9 (47 kDa) was processed into active
fragments (37/35 kDa) (Fig. 1E). Cleaved caspase-9 could
further process other caspase members, including caspase-3.
Next, to gain further insight into the apoptotic events
triggered by CPT, we stained cell colonies with cleaved
caspase-3 antibody (early marker for apoptosis) to determine
if this effector caspase was activated. Intense immunoreac-
tivity was observed 3 h after CPT addition (Fig. 1D). Active
executioner caspase-3 can further cleave downstream sub-
strates involved in apoptotic changes such as poly-(ADP-ribose)
polymerase (PARP). Time course assays revealed the presence
of cleaved PARP as early as 3 h after CPT addition and onwards
(Fig. 1E). Earlier studies suggest that caspase-cleaved PARP
translocates to the cytoplasm during apoptosis (Ang et al.,
2003). As shown in Fig. 1D (bottom panel) cytosolic PARP could
be seen 6 h after CPT withdrawal. PARP translocation waserine 15 in H9 cells. (A) Time course of p53 stabilization and
d by Western blotting with anti-p53 and anti-p53phospho-serine 15
ost drug removal (3 + 6, 3 + 12, respectively). Actin was used
μM) or untreatedH9 cells. The figure shows representative images of
transactivation domain). The nuclei were counterstained with DAPI.
e scale bars represent 100 μm. (C) Fluorescent immunoreactivity of
ffeine for 1 h and exposed to 1 μM CPT for 3 h. The scale bars
cells were harvested, and DNA oligomer levels were measured by
rs of untreated cells. Each bar represents the mean ± SEM of three
ility was measured by the XTT/PMS vital dye assay at 6 h after drug
ing CPT exposure). Results are presented as the percentage of the
percentage of viable cells assessed by Trypan blue exclusionmethod
nel). Each bar represents the mean ± SEM of three independent
t test was used to compare CPT plus PFT-μ treated samples to CPT
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This chronology is compatible with the involvement of caspase-
3 in PARP proteolysis.DNA damage-response signaling in CPT-treated hESCs
DNA topoisomerase I inhibitors exert their cytotoxic effects in
replicating cells by inducing DSBs (Arnaudeau et al., 2001). Theinduction of a wide range of cellular responses to DSBs depends
mainly on a functional ATM (Rotman and Shiloh, 1999). Upon
diverse genotoxic stress, ATM is recruited to the sites of DSBs,
where it becomes activated through autophosphorylation at
serine 1981 (Kobayashi et al., 2009). We investigated ATM
phosphorylation at this residue in H9 and HUES-5 (H5) cells by
fluorescent immunocytochemistry. As seen in Fig. 2A, phos-
phorylation of ATM at serine 1981 was evident in hESC nuclei
3 h after 1 μM CPT exposure.
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roles of ATM and DNA-PKcs in DSBs repair can be described as
complementary, since the presence of the two kinases is
absolutely necessary in order to avoid faulty DSBs rejoining
and achieve legitimate repair (Martin et al., 2012). It has
been reported that CPT treatment induces DNA-PKcs phos-
phorylation at serine 2056 (required for the repair of DSBs) in
human skin fibroblasts. Importantly, serine 2056 phosphory-
lation was associated with replication fork progression and
occurred only in cells synchronized in the S phase, suggesting
that DNA replication-associated DSBs activate DNA-PKcs (Chen
et al., 2005). To determine if CPT exposure leads to DNA-PKcs
phosphorylation in hESCs, we immunostained cells with anti-
pSer2056 DNA-PKcs antibody. A high nuclear immunoreactivity
was observed in H9 and H5 cells within 3 h of topoisomerase I
inhibition (Fig. 2A, bottom panel).
We then evaluated CPT-induced DNA damage response by
measuring the activation of ATM downstream target, H2AX
(Sordet et al., 2009). High levels of H2AX phosphorylated on
serine 139 (γH2AX) were detected in hESCs within 1 h of CPT
addition (data not shown) and along treatment (3 h) (Fig. 2A).
Interestingly, despite the small decrease in cell viability
observed in HF after CPT exposure, the phosphorylation of
ATM at serine 1981 and the levels of γH2AX immunoreactivity
exhibited by damaged fibroblasts were similar to those seen in
hESCs under the same experimental conditions (CPT, 1 μM,
3 h) (Supplementary Fig. 2).
To test whether ATM was responsible for H2AX phosphor-
ylation, we incubated H9 cells with 100 μM ATM-specific
inhibitor, KU55933, or 10 mM PI3KK-inhibitor, caffeine; 1 h
before and during treatment with the topoisomerase I inhibitor.
Consistent with previous data, our dose response experiments
revealed that a concentration of 100 μM KU55933 is needed to
effectively inhibit ATM signaling in hESCs (Momcilovic et al.,
2009). Incubation of hESCs with either of these inhibitorsFigure 4 p21Waf1 expression upon CPT exposure in undifferentiated
by real time RT-PCR in H9 cells and human foreskin fibroblasts (HF) im
removal (3 + 6 h, 3 + 12 h, respectively) with primers that amplified
mRNA fold change relative to untreated control cells, arbitrarily set as
performed in duplicate. Student's t test was used to compare CPT-trea
H9 cells (right panel) and human foreskin fibroblasts (left panel) im
removal (3 + 6 h, 3 + 12 h, respectively) using specific antibodies aga
differentiation on cell cycle structure. Pluripotent H9 cells were su
analyzed by flow cytometry at the indicated time points. DNA histo
undifferentiated H9 cells (day 0) and EBs (day 14) labeled with Ki67. T
100 μm (left panel). Analysis of p27Kip1 and p57Kip2 mRNA levels by real
points along differentiation. Graphs show mRNA fold change rela
differentiation, arbitrarily set as 1 for each of analyzed transcript (bott
in undifferentiated H9 cells and EBs treated or not with CPT (1 μMover
showmRNA fold change relative to undifferentiated control cells at ea
the mean ± SEM of three different experiments performed in duplicat
samples (*P b 0.05). Western blot analysis of EBs derived from H9 cel
p53, p73, p21Waf1 and Actin (loading control). (E) H9-derived EBs a
concentrations of CPT (1–10 μM) during 3 h. Cell viability was measu
Results are presented as the percentage of the viability of untreated E
cells assessed by Trypan blue exclusion method (right panel). Each b
performed in quintuplicates. (F) 12 h after CPT withdrawal (1 μM over
were measured by immunoassay. Results are presented as the percen
mean ± SEM of three independent experiments performed in triplicat
treated samples to untreated controls (*P b 0.05).impaired H2AX phosphorylation triggered by genotoxic stress,
which was manifested by a pronounced decrease in γH2AX
signal intensity (Fig. 2B).
Once activated, DNA-PKcs can phosphorylate a number
of substrates including H2AX (An et al., 2010). To assess
whether DNA-PKcs contributes to H2AX phosphorylation in
hESCs exposed to CPT, we used a selective inhibitor,
NU7026 (Callen et al., 2009). DNA-PKcs inhibitor treat-
ment (50 μM) resulted in reduced H2AX phosphorylation
(Fig. 2B). In all cases, basal levels of γH2AX were not affected
by these inhibitors at the concentrations and periods assayed
(data not shown). Collectively, these findings demonstrate
that CPT treatment leads to ATM and DNA-PKcs activation and
that both PI3KKs jointly contribute to H2AX phosphorylation in
hESCs.
The activation of ATM and DNA-PKcs and the subsequent
phosphorylation of its downstream targets in response to CPT
prompted us to investigate whether the inhibition of these
sensor kinaseswould affect the propensity of hESCs to undergo
cell death upon genotoxic stress. To address this issue, we
treated hESCs 1 h before and during CPT treatment (1 μM,
3 h) with KU55933 (100 μM) or NU7026 (50 μm) and measured
cell viability by XTT and Trypan blue exclusion assays. As seen
in Fig. 2C, the impairment of ATM or DNA-PKcs activity further
decreased the percentage of viable cells 6 h after CPT
removal. The presence of ATM or DNA-PKcs inhibitor did not
affect unstressed hESC viability during the timeframe of the
experiment (Fig. 2C).p53 is stabilized and phosphorylated on serine 15
upon CPT exposure in hESCs
As p53 is a major downstream effector of the ATM-mediated
response to DNA damage, we next assessed whetherand differentiated H9 cells. (A) Analysis of mRNA expression levels
mediately after 1 μM CPT treatment (3 h), 6 h or 12 h post CPT
p21Waf1. GAPDH expression was used as normalizer. Graphs show
1. Bars represent the mean ± SEM of three different experiments
ted to untreated samples (*P b 0.05). (B) Western blot analysis in
mediately after 1 μM CPT treatment (3 h), 6 h or 12 h post CPT
inst p21Waf1, p27Kip1 and Actin (loading control). (C) Effect of hESC
bjected to an embryoid body based differentiation protocol and
grams of H9 cells (right panel). Immunofluorescence staining of
he nuclei were counterstained with DAPI. The scale bars represent
time RT-PCR in undifferentiated H9 cells and EBs at indicated time
tive to undifferentiated control cells at each time point of
om panel) (D). Analysis of p21Waf1 mRNA levels by real time RT-PCR
a 3 h period) at indicated time points along differentiation. Graphs
ch time point of differentiation, arbitrarily set as 1. Bars represent
e. Student's t test was used to compare CPT-treated to untreated
ls, unstressed or exposed to CPT, using specific antibodies against
t day 14 of differentiation were treated or not with increasing
red by the XTT/PMS vital dye assay at 12 h after drug removal.
Bs (left panel). Histogram shows quantitative percentage of viable
ar represents the mean ± SEM of three independent experiments
a 3 h period) EBs (day14) were harvested, and DNA oligomer levels
tage of DNA oligomers of untreated EBs. Each bar represents the
es. In all cases, a paired Student's t test was used to compare CPT
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on serine 15 in pluripotent stem cells. To do so, CPT-treated
(1 μM for 3 h) H9 cells were harvested at different time points
post-treatment and subjected to Western blot assays. Immuno-
blot analysis revealed that p53 is stabilized and phosphorylated
on serine 15 in response to CPT. Enhanced levels of p53 and
phospho-p53(Ser15) were seen following a 3 h treatment with
CPT and onwards. p53 phosphorylation declined thereafter
and returned to baseline 12 h after drug removal (Fig. 3A).
Immunofluorescence studies showed a diffuse cytosolic and
nuclear staining pattern of p53 in untreated H9 hESCs (Fig. 3B).
However, upon genotoxic stress, p53 rapidly accumulated in
the nucleus and underwent N-terminal phosphorylation at
serine 15. This activation occurred within 1.5 h after CPTaddition (Fig. 3B). In contrast, p73, a p53 family member,
appeared widely distributed throughout the cytoplasm when
H9 hESCs were stained with an antibody that recognizes its
transactivation domain. CPT treatment did not induce changes
in p73 localization at least at the concentrations and time
points assayed (Fig. 3B).
To examine whether regulation of p53 protein through
post-translational mechanisms was achieved by ATM, we
pre-incubated H9 cells with KU55933 (100 μM) or caffeine
(10 mM) and exposed them to CPT for 1.5 or 3 h. As shown in
Fig. 3C, the presence of ATM inhibitor markedly reduced
phospho-p53(Ser15) fluorescent signal. Moreover, caffeine
treatment almost completely impaired p53 phosphorylation
in CPT-damaged hESCs.
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pifithrin-μ protects hESCs fromCPT-induced apoptosis
In many cell types, p53 rapidly mounts a direct mitochondrial
death program that precedes transcription-mediated apopto-
sis in response to intense stress (Vaseva and Moll, 2009). Thus,
to test whether this phenomenon was also operative in hESCs,
we treated H9 cells with pifithrin-μ (PFT-μ) a small molecule
that inhibits p53 binding to mitochondria by reducing its
affinity to Bcl-xL and Bcl-2 but has no effect on p53-dependent
transactivation (Strom et al., 2006). The aforementioned
factors are expressed in H9 cells (Romorini et al., 2012).
First, we determined apoptosis levels of CPT-treated hESCs,
in the presence or absence of PFT-μ, by quantifying DNA
oligomers. As seen in Fig. 3D, PFT-μ treatment (10 μM) reduced
approximately 30% the amount of CPT-induced DNA oligomers
in H9 hESCs. Then, to gain insight into the involvement of p53′
mitochondrial program in CPT induced apoptosis we perform
cell viability assays in PFT-μ treated or untreated H9 cells. By
XTT/PMS vital dye and Trypan blue exclusion assays we
determined that cell viability was increased by 27% and 22%,
respectively, in PFT-μ treated hESCs suggesting that in this
case, p53 is acting as a proapoptotic factor rather than an
antiapoptotic one. Interestingly, and according to previous
reports (Grandela et al., 2007), we also find that PFT-μ
protects cells from spontaneous apoptosis (10 to 15%) (Fig. 3D,
middle and right panels). Importantly, H9 cells displayed
similar levels of γH2AX immunoreactivity, p53 nuclear accu-
mulation and phosphorylation at serine 15 after CPT exposure,
either in the presence or in the absence of the inhibitor
(Supplementary Fig. 3).
DNA damage response toward topoisomerase I inhibi-
tion is achieved in the absence of cyclin-dependent
kinase inhibitor, p21Waf1, in undifferentiated hESCs
Depending on the extent of an insult, damaged DNA can
initiate a signaling pathway that leads either to cell cycle
arrest in which the cell is given the opportunity to repair
damaged DNA or to the complete disposal of the cell by
apoptosis. One of the main players deciding the cell fate
following DNA damage is p53 (Tian et al., 2012). In adult
cells, cell cycle arrest induced by p53 is mainly mediated by
the Cip/Kip family member, the CKI, p21Waf1 (Zhang et al.,
2010). The observed phosphorylation of p53 triggered by CPT
in hESCs prompted us to investigate p21Waf1 expression
levels in these cells upon damage. Quantitative RT-PCR
analysis revealed a robust induction of p21Waf1 mRNA 3 h
after 1 μM CPT addition (approximately 5 fold), similar to
that observed in HF (Fig. 4A). However, p21Waf1 transcript
levels were more sustained and strongly induced in fibro-
blasts than in hESCs after drug withdrawal (Fig. 4A). In
damaged HF the increase in p21Waf1 mRNA levels was also
reflected by changes in the protein levels (Fig. 4B, right
panel). Conversely and importantly, both in control and
CPT-treated H9 cells, p21Waf1 protein levels assessed by
Western blotting were undetectable at all tested time points
(Fig. 4B, left panel). These observations are in agreement
with previous results obtained with several hESC lines upon
treatment with different classes of DNA damaging agents
(Barta et al., 2010; Filion et al., 2009; Hyka-Nouspikel et al.,2012). Moreover, previous work had demonstrated that
multiple microRNAs, specifically expressed in pluripotent
cells, target the 3′-UTR of the p21Waf1 transcript to down-
regulate translation (Wang and Blelloch, 2009).
In addition, p27Kip1, another Cip/Kip family member, was
also undetectable by immunoblotting in these pluripotent
cells (Fig. 4B, left panel). An increasing number of reports
describe that active CDKs are required to initiate apoptotic
processes, including those induced by genotoxics (Janicke et
al., 2007; Yu et al., 2005). Importantly, ESCs exhibit high
levels of CDK activity, which are the consequence of the
absence or very weak expression of CKIs (Koledova et al., 2010).
The unique expression pattern of key cell cycle regulators in
hESCs may compose a scenario where genotoxic-induced
apoptosis is facilitated and may account for the increased loss
in cell viability observed in CPT-damaged H9 cells (Fig. 1A).p21Waf1 protein is induced in response to CPT in
differentiated hESCs
In vitro differentiation of hESCs into three-dimensional cell
aggregates, called embryoid bodies (EBs), is induced by
addition of serum and withdrawal of basic fibroblast growth
factor in a feeder-layer free culture. This differentiation
process is accompanied by decline in levels of proteins and
mRNAs associated with stemness, increased expression of
endodermal, ectodermal andmesodermal markers and chang-
es in cell cycle structure and dynamics. During differentiation
a decrease in pluripotency-associated gene expression (Oct-4,
Nanog), concomitant with an up-regulation of endodermal
(GATA-6, alpha fetoprotein), ectodermal (Pax-6), early meso-
dermal (brachury) and cardiac mesodermal (atrial natriuretic
peptide, cardiac troponin T)markers among others, is observed
(Scassa et al., 2011).
Different regulatorymechanisms create direct links between
cell cycle structure and differentiation stage during develop-
ment. Consequently, there is no definitive cell cycle but many
different cell cycle settings adapted to each stage of differen-
tiation. Thus, to assess differentiation-associated changes in
cell cycle profiles, we evaluated the cell cycle structure of
undifferentiated hESCs and EBs at day 7 or 14 from differenti-
ation onset. A progressive and sustained increase in the number
of cells residing in G0/1 phase and a reduction in the percentage
of cells transiting S phase was determined as differentiation
proceeded by flow cytometry analysis. A strong resemblance
between the cell cycle profiles of EBs (14 days) and human
foreskin fibroblasts was observed (Supplementary Fig. 1B). We
also examined the expression of the proliferation marker, Ki67,
in hESCs and EBs. As shown in Fig. 4C (right panel) at the
undifferentiated state, all H9 cells stained positively for Ki67
antibody, indicating the absence of quiescent (G0) cells.
Conversely, at day 14 of differentiation an increase in G0
phase population was evidenced by negative Ki67 labeling.
These data correlates with the cell cycle distribution
profiles exhibited by proliferating and differentiating
cells.
In consonance with these changes, a marked increase in
Cip/Kip family members mRNA levels was determined by real
time RT-PCR analysis. p21Waf1 was robustly induced (7.5 fold) in
EBs at day 14 of differentiation (Fig. 4D). Importantly, p57Kip2
mRNA level was up-regulated earlier and sustainably from day
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consistent with the specific role that this CKI plays in
embryonic development, where substantial and timely changes
of p57Kip2 are required for accurate differentiation of tissues
(Borriello et al., 2011). Conversely, p27Kip1 transcript levels did
not vary significantly at all time points assayed (Fig. 4C, bottom
panel). This correlates with the fact that p27Kip1 plays a critical
role in the establishment of quiescence and its expression is
increased in mitogen-deprived or terminally differentiated
cells (Gonzalez et al., 2003). Along differentiation, cells
undergo molecular changes that influence their fate. Thus,
the up-regulation of CKI levels observed herein can be
attributed, at least in part, to the facts that a timely regulated
exit from cell cycle is required for proper differentiation and a
decrease in CDK activities is necessary to safeguard excessive
apoptosis.
We further examined the effect triggered by CPT on
p21Waf1 mRNA levels at different time points during H9
hESC differentiation. As occur in several cell types,
p21Waf1 was markedly induced upon genotoxic stress at
all stages of differentiation (approximately 7 fold)
(Fig. 4D).
Several studies have clearly reported that p53 protein
levels increase swiftly in response to DNA damage. In addition,
a number of studies have recently shown that the p53 family
member, p73, is also up-regulated and activated by diverse
genotoxic stresses (Zaika et al., 2011). Here, we sought to
determine if these proteins were stabilized in EBs upon CPT
treatment. As seen in Fig. 4D (right panel) a robust increase in
p53 abundance was visible within 3 h of CPT addition, while
p73 protein levels remained unaffected. These findings suggest
that, unlike p53, p73 activation seems only to be triggered by a
subset of DNA damaging agents.
We next examined whether EBs at day 14 of differenti-
ation express p21Waf1 protein and, if this cell cycle inhibitor
was induced upon CPT-induced DNA damage. By Western
blot analysis we determined that p21Waf1 is clearly detect-
able in unstressed EBs. As expected, the stabilization of p53
following CPT exposure (1 μM, 3 h) was accompanied by a
robust induction of p21Waf1, a bona fide p53 target gene
(Fig. 4D, right panel).
Finally, to assess differentiated hESCs response to CPT, we
evaluated cell viability in EBs at day 14 of differentiation in
the presence of increasing doses of CPT during 3 h. We find
that approximately 91% of EBs survive at 1 μM CPT and 74% of
EBs remain viable at 10 μM CPT after a withdrawal period of
12 h (Fig. 4E), resembling the response described for HF
(Fig. 1A). Furthermore, we determined the percentage of
viable cells using Trypan blue staining. As shown in Fig. 4E
(right panel) a slight decrease in the percentage of viable cells
(23%) was observed 12 h after CPT removal (10 μM). Remark-
ably, no significant difference appeared between the amounts
of DNA oligomers present in stressed and in unstressed EBs as
judged by ELISA quantification (Fig. 4F). Thus, EBs are no
longer highly sensitive to CPT even when exposed to a 10-fold
higher dose than their differentiated counterparts. Interest-
ingly, the levels of γH2AX immunoreactivity displayed by
CPT-treated EBs (1 μM, 3 h) were similar to those seen in
damaged hESCs, suggesting that the differential response to
genotoxic observed between hESCs and EBs is not the
consequence of different extents of DNA damage (Supple-
mentary Fig. 2B). A priori, this attenuated response may beattributed, at least in part, to the marked reduction in the
fraction of cells transiting S phase (CPT-susceptible cells),
which decreased from approximately 65–60% at day 0 to 15%
at day 14 of differentiation (histograms, Fig. 4C).Discussion
Currently, the mechanisms that protect the genome in rapidly
proliferating hESCs are minimally understood. In the present
study we demonstrate that H9 and H5 hESC lines respond to
CPT by activating ATM and DNA-PKcs pathways. We find that,
once activated, these sensor kinases propagate signals to
downstream effectors that lead to H2AX and p53 phosphory-
lation and culminate in high apoptotic rate. Moreover, we
determined that the apoptotic process encompasses PS
exposure, caspase-9 and caspase-3 activation, PARP cleavage
and DNA fragmentation. Remarkably, the high apoptosis
displayed by hESCs seems not to be only a specific response
to CPT, as elevated apoptosis rates have been observed after
exposure to UV, ionizing radiation, and other DNA-damaging
agents (Hyka-Nouspikel et al., 2012). It thus appears that the
high propensity to apoptosis is a common characteristic of
hESCs, perhaps a strategy to ensure genomic integrity by
favoring apoptosis over DNA repair.
Importantly, in this study we also determined that the use
of small molecule inhibitors that impair ATM or DNA-PKcs
activity further sensitizes hESCs to CPT treatment. In this
sense, recruitment of kinase-dead ATM to sites of DNA damage
was found to occur normally (Daniel et al., 2012). Further-
more, autophosphorylation of DNA-PK is thought to be
necessary for events after recruitment of DNA-PKcs to DSBs
and for its ultimate dissociation (Reddy et al., 2004). Thus,
catalytically inhibited ATM or DNA-PK may impair the function
of repair factors by occluding their access to DSBs and severely
disturb the ability of cells to respond to damage.
Conflicting evidence has been reported as to whether p53 is
functional or non-functional in ES cells. However, despite the
nonfunctional p53-dependent G1/S checkpoint pathway, p53
protein has been shown to be stabilized and activated in hESCs
in response to gamma or UVC irradiation and to etoposide
(Grandela et al., 2007; Hyka-Nouspikel et al., 2012). Herein, we
present evidence that CPT treatment leads to p53 stabilization
and nuclear localization, supporting the concept that this
tumor suppressor is functional in hESCs. Moreover, in the
molecular setting displayed by hESCs, the proapoptotic activity
of p53 might prevail. Recently, it has been reported that
healthy undifferentiated H9 cells maintain Bax in its
preactivated state at the Golgi, in contrast to what occur
in other cell types in which Bax is typically present in an
inactive form in the cytosol (Dumitru et al., 2012). Interest-
ingly, in the same manuscript researchers found that upon
etoposide exposure, active Bax translocates from the Golgi to
the mitochondria in a p53-dependent manner. In this sense,
the CPT-induced programmed cell death achieved in the
presence of an operative p53′mitochondrial program supports
this concept.
At this point it is important to mention that although
apoptotic signals are generally mediated through two caspase-
dependent molecular pathways, namely, intrinsic and extrinsic
cascades, a third molecular pathway of programmed cell death
does exist. This pathway is characterized by nuclear
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(EndoG) that trigger chromatin condensation and DNA frag-
mentation independent of caspase activation (Galluzzi et al.,
2008). To this end, Tichy et al. (2013) recently reported that,
after etoposide treatment, mouse ESCs undergo charontosis, a
novel programmed cell death pathway, dependent upon p53
and EndoG. Importantly, in the mentioned study, researchers
find that PFT-μ addition reduces this novel type of cell death.
Thus, we cannot discard the possibility that charontosis is also
operative in hESCs.
Although p53 is stabilized and phosphorylated upon CPT
exposure, no p21Waf1 protein was detectable in damaged
undifferentiated H9 cells. In somatic cells, p21Waf1 appears to
be a principal mediator of cell cycle arrest in response to
different types of DNA damage, not only by inactivating
G1-phase cyclins/CDKs complexes, but also through other
processes, which possibly include direct interaction with PCNA
to inhibit DNA replication, and indirect effects mediated by
interaction with other cell cycle regulators (Cazzalini et al.,
2010). To this end, Mauro et al. have recently reported that
p21Waf1 plays a central role in the coordination of early steps
of DNA replication coupled to DSB repair triggered by the
DSB-inducing agents mitomycin C, CPT and etoposide (Mauro
et al., 2012). Importantly, in their study they determined that
human and murine p21Waf1 deficient cells are hypersensitive
to the mentioned genotoxics.
On the other hand, an active role for p21Waf1 in inhibiting
apoptosis has been described in several contexts. Indeed,
p21Waf1 was reported to have an antiapoptotic activity
through the inhibition of CDK activity required for activation
of the caspase cascade downstreamofmitochondria (Cazzalini
et al., 2010; Janicke et al., 2007). Thus the absence of p21Waf1
to ensure DNA repair and reduce apoptosis may be another
hallmark of hESCs to rapidly undergo apoptosis in early stages
of development upon encountering DNA damage.
The integration of opposing signals (e.g. repair DNA or
apoptosis) into a cellular consensus decision may require
significantly more complexity in somatic cells than in ES cells,
where a very limited number of signaling pathways suffice for
control of proliferation and survival. As differentiation
proceeds the cell cycle structure and apoptotic machinery
undergo dynamic changes. For instance, hESCs exhibit high
levels of CDK activity which is a consequence of the absence or
very weak expression of CKIs (Koledova et al., 2010). As
described herein hESC differentiation occurred concomitantly
with changes in cell cycle structure and robust induction of
CKIs, particularly p21Waf1 (Fig. 4). These changes may account
for the increase in cell viability exhibited by CPT-treated EBs.
Consistently, in this sense, Dumitru et al. reported that while
undifferentiated H9 hESCs have constitutively active Bax and
undergo rapid apoptosis in response to DNA damage, differ-
entiated counterparts have no constitutively active Bax, and
are no longer highly sensitive to DNA damage (Dumitru et al.,
2012). As a whole, these results open new questions: are the
atypical cell cycle structure, the absence of p21Waf1, the
presence of activated Bax and other, as yet, undetermined
features, hallmarks of hESC that endow them with the ability
to rapidly undergo apoptosis and thus maintain a pristine
population of pluripotent cells?
The genetic stability of hESCs has acquired a special
significance as researchmoves toward developing applications
in regenerative medicine for the differentiated derivatives ofthese cells. Thus, all attempts to define the mechanisms
mounted by hESC to cope with genomic threats could shed
light on the knowledge of stem cell biology and further use in
medicine.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.12.002.
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